{"id":5594,"date":"2011-07-01T09:30:00","date_gmt":"2011-07-01T09:30:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5594"},"modified":"2021-07-09T11:25:25","modified_gmt":"2021-07-09T11:25:25","slug":"the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/","title":{"rendered":"The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Zhu+M&amp;cauthor_id=21476027\">Mingming Zhu<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21476027\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Xu+X&amp;cauthor_id=21476027\">Xitao Xu<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Nie+F&amp;cauthor_id=21476027\">Fang Nie<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tong+J&amp;cauthor_id=21476027\">Jinlu Tong<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Xiao+S&amp;cauthor_id=21476027\">Shudong Xiao<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ran+Z&amp;cauthor_id=21476027\">Zhihua Ran<\/a>, Int J Colorectal Dis. 2011 Aug;26(8):999-1007.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Current data indicate that leukocytapheresis supplementation may be more efficacious on improving response and remission rates and tapering corticosteroid dosage with excellent tolerability and safety than conventional pharmacotherapy in patients with UC. In addition, more high-quality randomized controlled trials are required to confirm the higher efficacy of leukocytapheresis in patients with UC.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21476027\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/21476027\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Mingming Zhu&nbsp;1,&nbsp;Xitao Xu,&nbsp;Fang Nie,&nbsp;Jinlu Tong,&nbsp;Shudong Xiao,&nbsp;Zhihua Ran, Int J Colorectal Dis. 2011 Aug;26(8):999-1007. Current data indicate that leukocytapheresis supplementation may be more efficacious on improving response and remission rates and tapering corticosteroid dosage with excellent tolerability and safety than conventional pharmacotherapy in patients with UC. In addition, more high-quality randomized controlled trials are required to [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[306],"class_list":["post-5594","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Mingming Zhu&nbsp;1,&nbsp;Xitao Xu,&nbsp;Fang Nie,&nbsp;Jinlu Tong,&nbsp;Shudong Xiao,&nbsp;Zhihua Ran, Int J Colorectal Dis. 2011 Aug;26(8):999-1007. Current data indicate that leukocytapheresis supplementation may be more efficacious on improving response and remission rates and tapering corticosteroid dosage with excellent tolerability and safety than conventional pharmacotherapy in patients with UC. In addition, more high-quality randomized controlled trials are required to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:25:25+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/\",\"name\":\"The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2011-07-01T09:30:00+00:00\",\"dateModified\":\"2021-07-09T11:25:25+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/","og_locale":"de_DE","og_type":"article","og_title":"The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis - Adacyte","og_description":"Mingming Zhu&nbsp;1,&nbsp;Xitao Xu,&nbsp;Fang Nie,&nbsp;Jinlu Tong,&nbsp;Shudong Xiao,&nbsp;Zhihua Ran, Int J Colorectal Dis. 2011 Aug;26(8):999-1007. Current data indicate that leukocytapheresis supplementation may be more efficacious on improving response and remission rates and tapering corticosteroid dosage with excellent tolerability and safety than conventional pharmacotherapy in patients with UC. In addition, more high-quality randomized controlled trials are required to [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:25:25+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/","name":"The efficacy and safety of selective leukocytapheresis in the treatment of ulcerative colitis: a meta-analysis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2011-07-01T09:30:00+00:00","dateModified":"2021-07-09T11:25:25+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-efficacy-and-safety-of-selective-leukocytapheresis-in-the-treatment-of-ulcerative-colitis-a-meta-analysis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/5594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=5594"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=5594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}